Patent directory · USPTO A61K / A61P
Patents matching “ONC”
274 pharma patents match "ONC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 274 pharmaceutical patents matching "ONC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11419934
Use of VDAS to enhance immunomodulating therapies against tumors
granted -
US 11357795
Combination immunotherapies for treatment of cancer
granted -
US 11338003
Methods of treating bladder cancer with an oncolytic virus
granted -
US 11312786
Oncofetal antigen binding proteins and related compositions and methods
granted -
US 11298378
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11291663
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11285145
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 11246930
Reoviruses having modified sequences
granted -
US 11242380
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
granted -
US 11229702
High concentration formulations of adalimumab
granted -
US 11207314
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11208405
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11207351
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11202825
Attenuated infectious bronchitis virus
granted -
US 11202802
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11191783
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11166985
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11135247
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11124839
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11117934
Oncolytic virus platform to treat cancers with myxoma virus
granted -
US 11103552
High concentration VEGF receptor fusion protein containing formulations
granted -
US 11077241
Standardizations and medical devices for the preparation of platelet rich plasma (PRP) or bone marrow concentrate (BMC) alone or in combination with hyaluronic acid
granted -
US 11071755
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11065285
Biomarkers and combination therapies using oncolytic virus and immunomodulation
granted